RECENT ANALYSIS
Committee Approves FY 2026 Funding Bill for USDA, FDA, and Rural Development Along Party Lines
The House Committee on Appropriations convened a markup of the Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies Bill for fiscal year (FY) 2026 (text; summary; report language). A summary of key nutrition, rural development, and FDA provisions is included at the end of our full markup summary. The bill was favorably forwarded to the House with a vote of 35-27. What… (McClurg, June 25, 2025) #Budget, #Food and Drug Administration, #Nutrition, #Rural Health
CRS Outlines Legislative Paths for AI Regulation as Congress Considers A 10-Year Moratorium on State AI Laws
The Congressional Research Service issued a report presenting Congress with a broad overview of regulatory options and policy considerations for artificial intelligence (AI). The report outlines how U.S. federal efforts have so far focused on agency-specific oversight, voluntary industry commitments, and the exploration of whether new authorities are needed. CRS contrasts the U.S. approach with international models, noting that while… (Colocho, June 24, 2025) #Budget, #Costs, #Health Information Technology
Award Terms Updated to Require Health Centers to Provide Insulin and EpiPens at or Below 340B Pricing
Pursuant to President Trump’s Executive Order Lowering Drug Prices by Putting Americans First, today, the Health Resources and Services Administration (HRSA) announced that it has updated its award terms to require HRSA-funded health centers to provide insulin and injectable epinephrine to low-income patients at or below the price paid by the center through the 340B Drug Pricing Program. Whereas during President… (Slifer, June 24, 2025) #340B, #Community Health Centers, #Prescription Drugs